Labcorp Holdings Deferred compensation liability increased by 2.0% to $153.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $134.00M to $153.50M. Over 5 years (FY 2020 to FY 2025), Deferred compensation liability shows an upward trend with a 11.0% CAGR.
other_fair_value_liabilities_measured_on_recurring_basis_caa045| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $99.20M | $99.00M | $104.40M | $103.50M | $94.90M | $93.70M | $96.90M | $102.70M | $101.10M | $105.40M | $107.40M | $121.00M | $125.30M | $127.30M | $132.50M | $134.00M | $138.60M | $146.80M | $150.50M | $153.50M |
| QoQ Change | — | -0.2% | +5.5% | -0.9% | -8.3% | -1.3% | +3.4% | +6.0% | -1.6% | +4.3% | +1.9% | +12.7% | +3.6% | +1.6% | +4.1% | +1.1% | +3.4% | +5.9% | +2.5% | +2.0% |
| YoY Change | — | — | — | — | -4.3% | -5.4% | -7.2% | -0.8% | +6.5% | +12.5% | +10.8% | +17.8% | +23.9% | +20.8% | +23.4% | +10.7% | +10.6% | +15.3% | +13.6% | +14.6% |